Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 May 29:14:103-108.
doi: 10.2147/VHRM.S160883. eCollection 2018.

Expression of phospholipase A2 receptor and IgG4 in patients with membranous nephropathy

Lei Liu  1 , Baochao Chang  1 , Xueping Wu  1 , Yaling Guo  1 , Yan Pan  1 , Lijuan Yang  2
Affiliations

Expression of phospholipase A2 receptor and IgG4 in patients with membranous nephropathy

Lei Liu et al. Vasc Health Risk Manag. .

Abstract

Objectives: The aims of this study were to detect the expression of M phospholipase A2 receptor (PLA2R) in the kidney tissue of patients with idiopathic membranous nephropathy (IMN), secondary membranous nephropathy (SMN), and the nonmembranous nephropathy (non-MN), to evaluate the value of PLA2R in the kidney tissue and serum anti-PLA2R antibody in the diagnosis of membranous nephropathy (MN), and to explore the relationship between PLA2R of the kidney tissue or serum anti-PLA2R antibody and clinical features of MN.

Methods: The kidney tissue was collected by kidney biopsy. Immunofluorescence assay was used to detect the level of PLA2R and IgG4 antigen in kidney tissue. Furthermore, the level of the PLA2R was detected using the enzyme-linked immunosorbent assay (ELISA). The positive and negative rates of PLA2R and IgG4 in different diseases and the sensitivity and specificity, were calculated using the statistical method. The specificity and coincidence rate of PLA2R or anti-PLA2R used in the differential diagnosis of IMN and SMN were evaluated.

Results: The expression intensities of anti-PLA2R antibody and IgG4 were significantly higher in patients with IMN than in patients with SMN but are not non-MN. There was no significant difference in anti-PLA2R antibody and IgG4 in patients with SMN and non-MN. The coincidence rate of serum anti-PLA2R antibody and PLA2R in kidney tissue was 100%.

Conclusion: The expression of PLA2R and IgG4 antibody had great significance in the pathological diagnosis of MN. The detection of the serum anti-PLA2R antibody had great diagnostic value in diagnosing MN.

Keywords: IgG4; PLA2R; membranous nephropathy.

PubMed Disclaimer

Conflict of interest statement

Disclosure The authors report no conflicts of interest in this work.

Figures

Figure 1
Figure 1
Fluorescence values among the three groups. Notes: The fluorescent-labeled goat antihuman IgG was combined with PLA2R, which expressed on the glomerular capillary filtration membrane, and then formed the immunocomplex. Under immunofluorescence microscope, there had a significant difference expression in three groups. Magnification ×400. Abbreviations: IMN, idiopathic MN; MN, membranous nephropathy; PLA2R, phospholipase A2 receptor; SMN, secondary MN.
See this image and copyright information in PMC

References

    1. Xie J, Chen N. Primary glomerulonephritis in mainland China: an overview. Contrib Nephrol. 2013;181:1–11. - PubMed
    1. Beck LH, Jr, Bonegio RG, Lambeau G, et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med. 2009;361(1):11–21. - PMC - PubMed
    1. Wang LJ, Shang MH, Zhuge YF, et al. Expression of renal PLA2R in patients with idiopathic membranous nephropathy and its relationship with the curative effect of immunotherapy. Zhonghua Yi Xue Za Zhi. 2016;96(1):4–8. - PubMed
    1. Lin W, Li H, Li X, et al. The relationship between anti-phospholipase A2 receptor antibody and idiopathic membranous nephropathy. Zhonghua Nei Ke Za Zhi. 2015;54(9):783–788. - PubMed
    1. Radice A, Trezzi B, Maggiore U, et al. Clinical usefulness of autoantibodies to M-type phospholipase A2 receptor (PLA2R) for monitoring disease activity in idiopathic membranous nephropathy (IMN) Autoimmun Rev. 2016;15(2):146–154. - PubMed

LinkOut - more resources